High numbers of tumor-associated CD8+ and CD4+ T cells, with Th1 profile, and of PB- and tumor-associated NK cells have been correlated with better prognosis in CRC (1, 14, 26). The gene discussed is CD8A; the disease is colorectal carcinoma.